medication safety anticoagulation management.ppt

Upload: andrikusuma

Post on 02-Jun-2018

226 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    1/39

    September 10, 2008

    Medication Safety:Anticoagulation Management

    Carla S. Huber, ARNP MS

    Community Anticoagulation Therapy (CAT)Clinic

    Cedar Rapids, IA 52401

    515-558-4046

    [email protected]

    www.crhealthcarealliance.org

    mailto:[email protected]://www.crhealthcarealliance.org/http://www.crhealthcarealliance.org/mailto:[email protected]
  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    2/39

    Objectives

    Identify the challenges and barriers to

    implementing medication safety tools Explain the importance of utilizing evidence-

    based guidelines for managing warfarin

    therapy

    Explain the importance of education forpatients taking warfarin

    List the advantages of a dedicated

    anticoagulation clinic

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    3/39

    PIPS Grant

    Specific Aims

    Education and training in principles of ISO 9001quality management systems

    Establish the anticoagulation clinic

    Determine other uses of ISO framework within the

    healthcare community

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    4/39

    % Warfarin of All ADE's 04/02 through 11/04

    0%

    5%10%15%20%

    25%30%35%40%

    Oct-02

    Dec-02

    Feb-03

    Apr-03

    Jun-03

    Aug-03

    Oct-03

    Dec-03

    Feb-04

    Apr-04

    Jun-04

    Aug-04

    Oct-04

    %WarfarinADE's

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    5/39

    National Quality Forum (2004)

    Safe Practices:

    #1 - Creation of a healthcare culture of safety #18Utilization of dedicated anti-thrombotic

    services that facilitate coordinated care

    management

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    6/39

    Medication Statistics

    60% of older Americans use five or more

    different medications per week 20% of older Americans take 10 different

    medications per week

    Americans older than 65 have more than

    175,000 emergency room visits/year foradverse drug events

    Source CDC

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    7/39

    Medication Statistics

    In the US age >65 comprise 15% of population and

    buy 30% of all prescription drugs and 40% of OTC

    meds http://www.webmd.com/content/article/6/1680_51638.htmretrieved 1/22/07

    Up to 60% of all medications prescribed are taken

    incorrectly or not at all

    90% of elderly patients make some medicationerrors

    35% of the elderly make potentially serious errors

    http://www.itaa.org/isec/events/presentationsretrieved 1/12/07

    http://www.webmd.com/content/article/6/1680_51638.htm%20retrieved%201/22/07http://www.webmd.com/content/article/6/1680_51638.htm%20retrieved%201/22/07http://www.itaa.org/isec/events/presentationshttp://www.itaa.org/isec/events/presentationshttp://www.webmd.com/content/article/6/1680_51638.htm%20retrieved%201/22/07http://www.webmd.com/content/article/6/1680_51638.htm%20retrieved%201/22/07
  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    8/39

    Anticoagulation Clinics

    Dedicated service to manage patients on

    anticoagulation medications

    Use evidence based guidelines to make dosing

    decisions

    Specially trained nurses, pharmacists

    Decrease complications of anticoagulants and

    decrease ER visits and hospital admissions

    Pts. are in INR range greater percent of the time

    Improve physician and staff efficiency

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    9/39

    Why dedicated anticoagulation clinics?

    Use of evidence-based guidelines

    American College of Chest Physicians Improved outcomes

    Increased time in INR range

    Decreased bleeding and clotting events

    Decreased hospitalizations related toanticoagulation events

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    10/39

    Patient Safety Goal

    Joint Commission 2009 National Patient

    Safety Goal #3: Improve the safety of using medications

    Anticoagulation therapy, 3.05.01

    Reduce the likelihood of patient harm associated with

    the use of anticoagulation therapy

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    11/39

    Policies and Procedures

    The organization needs to identify and

    determine which additional procedures needto be documented to create consistentprocesses.

    Physicians Clinic of Iowa currently has over

    400 documented policies and procedures. The Community Anticoagulation Therapy

    Clinic (CAT Clinic) currently has over 70documented policies and procedures.

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    12/39

    Note the:Format and color

    Document

    number

    PurposeDefinition

    Procedure orflowchart

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    13/39

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    14/39

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    15/39

    Flow of current clinic processes

    Completed a process flow of current (2005)anticoag clinic processes

    Lots of variationseveral nurses providinginformation about dose changes to patients

    Little use of evidence-based guidelines

    Waiting for lab results Pt. satisfaction low

    Pt. education 15 minutes

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    16/39

    Community Anticoagulation

    Therapy (CAT) Clinic

    Provide patient education 60-90 minutes andongoing

    Patients go to lab of their choice, POCtesting, home INR monitor

    INRs faxed to CAT Clinic or provided via web

    Pt. notified of results same day and dosingdecision made based on guidelines

    Referring physician notified of all results andchanges in warfarin therapy

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    17/39

    ACCP Guidelines

    Why use guidelines to manage

    anticoagulation? To reduce gaps in knowledge

    To reduce safety issues surrounding

    anticoagulation

    Both of the above promote standardization in thepractice of managing patients taking warfarin

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    18/39

    Guidelines

    Maintenance Therapy

    Make small changes to warfarinincrease ordecrease dose 5-15%, if INR between 1.0 and 5.0

    Calculate the weekly dose and adjust accordingto the total weekly dose. If patient taking5mg/day=35mg/week. If dose increased or

    decreased by 10% = 3.5mg/week Check INR every 4 weeks at a minimum

    Give the warfarin time to work- maytake 48 hours to see a change in INR

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    19/39

    What affects how warfarin works?

    Other medicationsantibiotics, herbs,aspirin products, chemotherapy, NSAIDs,amiodarone (decrease warfarin by as muchas 30%)

    Dietamount of vitamin K in foods

    Alcoholwarfarin is synthesized in the liver Exercise

    Stress

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    20/39

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    21/39

    What does all of this mean?

    It takes time to educatemore than a 10 or

    15 minute office visit

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    22/39

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    23/39

    www.ahrq.gov/consumer/coumadin.pdf

    http://www.ahrq.gov/consumer/coumadin.pdfhttp://www.ahrq.gov/consumer/coumadin.pdf
  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    24/39

    Medical Record

    CAT Clinic utilizes a web-based electronicmedical record www.inrpro.com

    Automatic list of patients due for INRs

    Warfarin logeasy to read Control Chart

    Next apt. date Sent to referring physician

    Reports at the click of a button

    http://www.inrpro.com/http://www.inrpro.com/
  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    25/39

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    26/39

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    27/39

    www.inrpro.com

    http://www.inrpro.com/http://www.inrpro.com/
  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    28/39

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    29/39

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    30/39

    Benchmark - JCAHO, Journal of Quality

    and Safety, Vol. 29 (12), 2003 and

    AC Forum 2007.

    Median % of Time in INR Range (CAT Clinic) = 59%

    Percent of Time Patients in INR Range

    Rosendaal

    0

    10

    20

    3040

    50

    60

    70

    80

    90

    100

    Jun-06

    Jul-06

    Aug-06

    Sep-06

    Oct-06

    Nov-06

    Dec-06

    Jan-07

    Feb-07

    Mar-07

    Apr-07

    May-07

    Jun-07

    Jul-07

    Aug-07

    Sep-07

    Oct-07

    Nov-07

    Dec-07

    Jan-08

    Feb-08

    Mar-08

    Apr-08

    May-08

    Jun-08

    Month

    CAT Patients

    Prior visits

    benchmark

    Good

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    31/39

    CAT Clinic patients in tighter range

    Percent of Time Patients in INR Range +/- 0.2

    0.0

    10.0

    20.0

    30.0

    40.0

    50.0

    60.0

    70.0

    80.0

    90.0

    100.0

    Aug-06

    Sep-06

    Oct-06

    Nov

    -06

    Dec-06

    Jan-07

    Feb-07

    Mar-07

    Apr-07

    May-07

    Jun-07

    Jul-07

    Aug-07

    Sep-07

    Oct-07

    Nov

    -07

    Dec-07

    Jan-08

    Feb-08

    Mar-08

    Apr-08

    May-08

    Jun-08

    CAT Patients

    +/- 0.2

    Prior visits+/- 0.2

    Good

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    32/39

    This graph shows a decrease in the number of physician contacts (the

    number of times the CAT Clinic nurse needs to contact the referring

    physician). This number should decrease as patients are in INR range a

    greater percent of the time.

    Physician Contacts

    0%

    5%

    10%

    15%

    20%

    25%

    30%

    Apr-06

    May-06

    Jun-06

    Jul-06

    Aug-06

    Sep-06

    Oct-06

    Nov-06

    Dec-06

    Jan-07

    Feb-07

    Mar-07

    Apr-07

    May-07

    Jun-07

    Jul-07

    Aug-07

    Sep-07

    Oct-07

    Nov-07

    Dec-07

    Jan-08

    Feb-08

    Mar-08

    Apr-08

    May-08

    Jun-08

    Month

    All patients Median

    Good

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    33/39

    The graph shows the percent of INRs greater than 5. There have been two

    associated major bleeds in 2007 (GI bleeding, requiring hospitalizations, one

    pt. taking NSAID, another pt. taking ASA and started on Amiodarone) with the

    INRs greater than 5.Benchmark 7%, Chiquette,

    Amato, Bussey, 1999.

    % of INRs > 5

    0.00%

    0.50%

    1.00%

    1.50%

    2.00%

    2.50%

    3.00%

    3.50%

    3rdQ

    200

    4th

    Q200

    1stQ

    200

    2ndQ

    200

    3rdQ

    200

    4th

    Q200

    1stQ

    200

    2ndQ

    200

    Good

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    34/39

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    35/39

    Average Compliance Score

    80

    82.5

    85

    87.5

    90

    92.5

    95

    97.5

    100

    Ma

    y-06

    Ju

    n-06

    Jul-06

    Au

    g-06

    Se

    p-06

    Oct-06

    No

    v-06

    De

    c-06

    Ja

    n-07

    Fe

    b-07

    Mar-07

    Apr-07

    Ma

    y-07

    Ju

    n-07

    Jul-07

    Au

    g-07

    Se

    p-07

    Oct-07

    No

    v-07

    De

    c-07

    Ja

    n-08

    Fe

    b-08

    Mar-08

    Apr-08

    Ma

    y-08

    Ju

    n-08

    Ave. compliance % Average

    Good

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    36/39

    www.crhealthcarealliance.org

    Toolkit Items

    ISO Executive and Staff Training Modules

    INRPro Databasewww.inrpro.com Organized Document System70 documents

    Compliance Assessment Scale

    Patient EducationYour Guide to

    Coumadin/Warfarin Therapy

    Staff Education Modules

    http://www.inrpro.com/http://www.inrpro.com/
  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    37/39

    Summary

    Identify the challenges and barriers to

    implementing medication safety tools

    Explain the importance of utilizing evidence-

    base guidelines for managing warfarin

    therapy

    Explain the importance of education forpatients taking warfarin

    List the advantages of dedicated

    anticoagulation clinics

  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    38/39

    References

    www.crhealthcarealliance.orgCedar Rapids

    Healthcare Alliance

    www.chest.orgMost recent anticoagulation

    management guidelines

    My Guide to Warfarin Therapy

    www.crhealthcarealliance.org

    Your Guide to Coumadin/Warfarin Therapy

    www.ahrq.gov/consumer/coumadin.pdf

    www.inrpro.com

    http://www.crhealthcarealliance.org/http://www.chest.org/http://www.crhealthcarealliance.org/http://www.ahrq.gov/consumer/coumadin.pdfhttp://www.inrpro.com/http://www.inrpro.com/http://www.ahrq.gov/consumer/coumadin.pdfhttp://www.crhealthcarealliance.org/http://www.chest.org/http://www.crhealthcarealliance.org/
  • 8/11/2019 Medication Safety Anticoagulation Management.ppt

    39/39

    Carla S. Huber, ARNP MS

    CAT Clinic

    600 7thStreet SE

    Cedar Rapids, IA 52401

    [email protected]

    www.crhealthcarealliance.org

    mailto:[email protected]://www.crhealthcarealliance.org/http://www.crhealthcarealliance.org/mailto:[email protected]